07:00 , Oct 8, 2012 |  BC Week In Review  |  Clinical News

CoaguChek XS Plus regulatory update

Roche said FDA granted CLIA-waived status for its CoaguChek XS Plus system for anticoagulation monitoring as measured by prothrombin time/international normalized ratio (PT/INR) during warfarin therapy. Roche said the test, which has been available to...